Current Status and Prospects of Diagnostic Methods for Diabetic Lower-Extremity ArterialDisease
Yang Yuxiang1#*, Shi Zhuangzhi1, Zhang Fu1, Zhang Linshan2, Zhu Yan3, Li Zhonglin4
1(School of Engineering and Design,Hunan Normal University, Changsha 410081,China) 2(Department of Endocrinology,Zhongshan Hospital,Fudan University,Shanghai 200032,China) 3(Department of Endocrinology,The First Affiliated Hospital of Hunan Normal University,Changsha 410005,China) 4(Xiangtan Diabetes Hospital,Xiangtan 411100,Hunan,China)
Abstract：Diabetes mellitus (DM) lower extremity arterial disease (LEAD) is one of the main pathological factors leading to diabetic foot (DF) that is the most serious chronic complications of DM with the highest treatment cost. Therefore, timely diagnosis of LEAD is crucial to prevent the occurrence of DF. This paper summarized the LEAD diagnostic methods commonly used in clinic, including subjective evaluation, image detection and physiological parameter detection, and expounded the basic principles, advantages and disadvantages of these methods. In view of the current increasing demand for early diagnosis of LEAD, the research progress of microvascular disease (MVD) and local arterial pulse wave velocity (PWV) detection technology and their feasibility of clinical applications were summarized, which is expected to become a breakthrough for early diagnosis of asymptomatic LEAD in DM patients.
作者简介: #中国生物医学工程学会会员(Member,Chinese Society of Biomedical Engineering)
引用本文:
杨宇祥, 史壮志, 张甫, 张林杉, 朱艳, 李中林. 糖尿病下肢动脉病变诊断方法的现状与展望[J]. 中国生物医学工程学报, 2022, 41(4): 473-484.
Yang Yuxiang, Shi Zhuangzhi, Zhang Fu, Zhang Linshan, Zhu Yan, Li Zhonglin. Current Status and Prospects of Diagnostic Methods for Diabetic Lower-Extremity ArterialDisease. Chinese Journal of Biomedical Engineering, 2022, 41(4): 473-484.
[1] American Diabetes Association (ADA). Classification and diagnosis of diabetes: standards of medical care in diabetes—2020[J]. Diabetes Care, 2020, 43(Supplement 1): S14-S31. [2] Davies J, Yudkin JS, Atun R. Liberating data: the WHO response-authors′ reply[J]. Lancet Diabetes Endocrinol, 2016, 4(8): 648-649. [3] 郭立新. 糖尿病的流行势态和应对策略[J]. 中国临床保健杂志, 2020, 23(4): 433-436. [4] Ogurtsova K, Da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040[J]. Diabetes Res Clin Pract, 2017, 128: 40-50. [5] Hippisley-Cox JC. Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care[J]. BMJ, 2016, 352:i1450. [6] 蔡淳, 贾伟平. 中国糖尿病的社区化管理[J]. 中国科学:生命科学, 2018, 48(8): 820-826. [7] 杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学:生命科学, 2018, 48(8): 812-819. [8] Tresierra-Ayala MÁAGR. Association between peripheral arterial disease and diabetic foot ulcers in patients with diabetes mellitus type 2[J]. Medicina Universitaria, 2017, 19(76): 123-126. [9] Bus SA, Netten JJ, Lavery LA, et al. IWGDF guidance on the prevention of foot ulcers in at‐risk patients with diabetes[J]. Diabetes Metab Res Rev, 2016, 32(S1): 16-24. [10] Verma S, Mazer CD, Al-Omran M, et al. Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG outcome[J]. Circulation, 2018, 137(4): 405-407. [11] Buso G, Victor A, Lucia M. Lower extremity artery disease in patients with type 2 diabetes[J]. Eur J Prev Cardiol, 2019, 26(2_suppl): 114-124. [12] Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet, 2013, 382(9901): 1329-1340. [13] Soyoye DO, Abiodun OO, Ikem RT, et al. Diabetes and peripheral artery disease: A review[J]. World J Diabetes, 2021, 12(6): 827-838. [14] Zhang Y, Lazzarini PA, Mcphail SM, et al. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016[J]. Diabetes Care, 2020, 43(5): 964-974. [15] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. [16] Lewis JE, Morris K, Powell T, et al. Combining diabetic foot and retinopathy screening: A step in the right direction? - a feasibility study[J]. SAGE Open Med, 2020, 8: 2050312120946244. [17] Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States[J]. Circulation, 2004, 110(6): 738-743. [18] Pande RL, Perlstein TS, Beckman JA, et al. Secondary prevention and mortality in peripheral artery disease: national health and nutrition examination study, 1999 to 2004[J]. Circulation, 2011, 124(1): 17-23. [19] Fowkes FGR, Housley E, Cawood EH, et al. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population[J]. Int J Epidemiol, 1991, 20(2): 384-392. [20] Arora E, Maiya AG, Devasia T, et al. Prevalence of peripheral arterial disease among type 2 diabetes mellitus in coastal Karnataka[J].Diabetes Metab Syndr, 2019, 13(2): 1251-1253. [21] Crawford F, Welch K, Andras A, et al. Ankle brachial index for the diagnosis of lower limb peripheral arterial disease[J]. Cochrane Database Syst Rev, 2016, 9(9): Cd010680. [22] Barrera-Guarderas F, Carrasco-Tenezaca F, De La Torre-Cisneros K. Peripheral artery disease in type 2 diabetes mellitus: survival analysis of an Ecuadorian population in primary care[J]. J Prim Care Community Health, 2020, 11: 2150132720957449. [23] Mejias SG, Ramphul K. Prevalence of peripheral arterial disease among diabetic patients in Santo Domingo, Dominican Republic and associated risk factors[J]. Arch Med Sci Atheroscler Dis, 2018, 3(1): 35-40. [24] Montero-Monterroso JL, Gascón-Jiménez JA, Vargas-Rubio MD, et al. Prevalence and factors associated with peripheral artery disease in patients with type 2 diabetes mellitus in Primary Care[J]. Semergen, 2015, 41(4): 183-190. [25] Belch J, Maccuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease[J]. BMJ, 2008, 337: a1840. [26] Akalu Y, Birhan A. Peripheral arterial disease and its associated factors among type 2 diabetes mellitus patients at debre tabor general hospital, Northwest Ethiopia[J]. J Diabetes Res, 2020, 2020: 9419413. [27] Akram J, Aamir AU, Basit A, et al. Prevalence of peripheral arterial disease in type 2 diabetics in Pakistan[J]. J Pak Med Assoc, 2011, 61(7): 644-648. [28] Lange S, Diehm C, Darius H, et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes[J]. Exp Clin Endocrinol Diabetes, 2004, 112(10): 566-573. [29] Soyoye DO, Ikem RT, Kolawole BA, et al. Prevalence and correlates of peripheral arterial disease in nigerians with type 2 diabetes[J]. Adv Med, 2016, 2016: 3529419. [30] Stoberock K, Kaschwich M, Nicolay SS, et al. The interrelationship between diabetes mellitus and peripheral arterial disease - a systematic review[J]. Vasa, 2021, 50(5): 323-330. [31] Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J]. JAMA, 2017, 317(24): 2515-2523. [32] Zhang X, Ran X, Xu Z, et al. Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study[J]. J Diabetes Complications, 2018, 32(2): 150-156. [33] 谷涌泉. 中国糖尿病足诊治指南[J]. 中国临床医生杂志, 2020, 48(1): 19-27. [34] Aboyans V, SevestreI Désormais MA. Epidemiology of lower extremity artery disease[J]. Presse Med, 2018, 47(1):38-46. [35] Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients[J]. J Vasc Surg, 2015, 61(3 Suppl): 42s-53s. [36] Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes--a review[J]. Diabet Med, 2010, 27(1): 4-14. [37] Cronin CT, Mccartan DP, Mcmonagle M, et al. Peripheral artery disease: a marked lack of awareness in Ireland[J]. Eur J Vasc Endovasc Surg, 2015, 49(5): 556-562. [38] Hjelm K, Beebwa E. The influence of beliefs about health and illness on foot care in ugandan persons with diabetic foot ulcers[J]. Open Nurs J, 2013, 7: 123-132. [39] 林光豪, 叶朝辉, 陈林海, 等. 糖尿病下肢血管病变早期检测方法的研究进展[J]. 现代实用医学, 2019, 31(2): 277-280. [40] American Diabetes Association (ADA). Microvascular complications and foot care: standards of medical care in diabetes—2018[J]. Diabetes Care, 2018, 41(Supplement 1): S105-S118. [41] Agarwal AK, Singh M, Arya V, et al. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors[J]. J Assoc Physicians India, 2012, 60(7): 28-32. [42] Nativel M, Potier L, Alexandre L, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review[J]. Cardiovasc Diabetol, 2018, 17(1): 138. [43] 柴萌, 张海涛, 黄丛春, 等. 无创检查在糖尿病足下肢血管病变中的诊断价值:与DSA对照研究[J]. 医学影像学杂志, 2007, 18(3): 300-303. [44] 李虎山. 皮温检测在糖尿病下肢血管狭窄病变筛检中的应用[C]//中华医学会烧伤外科学分会学术年会. 南昌:中华医学会,2009. [45] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志, 2014, 30(8): 893-942. [46] 刘瑾, 路潜, 袁戈恒, 等. 糖尿病患者高危足的筛查方法[J]. 中国糖尿病杂志, 2016, 24(11): 1052-1056. [47] Hardman RL, Jazaeri O, Yi J, et al. Overview of classification systems in peripheral artery disease[J]. Semin Intervent Radiol, 2014, 31(4): 378-388. [48] Aboyans V, Ricco JB, Bartelink ML, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS)[J]. Eur J Vasc Endovasc Surg, 2018, 55(3): 305-368. [49] 袁丁, 赵纪春, 马玉奎, 等. 2017年ESC外周动脉疾病诊断治疗指南解读——下肢动脉疾病篇[J]. 中国循证医学杂志, 2017, 17(12): 1381-1387. [50] Darling JD, Mccallum JC, Soden PA, et al. Predictive ability of the society for vascular surgery wound, ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations[J]. Journal of Vasc Surg, 2017, 65(3): 695-704. [51] 李子彦, 杨秀荣, 肖东健, 等. 无创影像检查方法诊断糖尿病下肢动脉病变的价值[J]. 糖尿病新世界, 2019, 22(24): 56-57. [52] 李佳, 王俊. CTA、CE-MRA、DUS三种影像学方法对糖尿病下肢动脉病变的诊断价值对比[J]. 医学影像学杂志, 2019, 29(3): 175-178,182. [53] 周航. 3D CE-MRA在糖尿病足下肢动脉病变诊断中的研究价值[J]. 糖尿病新世界, 2016, 19(6): 129-130. [54] Mishra A, Jain N, Bhagwat A. CT angiography of peripheral arterial disease by 256-slice scanner: accuracy, advantages and disadvantages compared to digital subtraction angiography[J]. Vasc Endovascular Surg, 2017, 51(5): 247-254. [55] Marques C, Dias-Neto M, Sampaio S. Clinical outcomes after digital subtraction angiography versus computed tomography angiography in the preoperative evaluation of lower limb peripheral artery disease[J]. Rev Port Cir Cardiotorac Vasc, 2018, 25(3-4): 133-140. [56] Meyersohn NM, Walker TG, Oliveira GR. Advances in axial imaging of peripheral vascular disease[J]. Curr Cardiol Rep, 2015, 17(10): 87. [57] 蒋春雨, 王建波, 程永德, 等. 糖尿病足患者下肢血管MRA与CTA诊断对比研究[J]. 影像诊断与介入放射学, 2015, 24(3): 220-224. [58] 蒲蔚荣, 温智峰, 刘晓宇, 等. 超声测定肱动脉内皮舒张功能诊断初诊2型糖尿病患者下肢动脉早期病变的价值[J]. 浙江医学, 2018, 40(23): 2585-2589. [59] 张庆梅, 周宇, 王薇. 踝臂指数与下肢动脉彩超对糖尿病下肢血管病变的诊断价值[J]. 中国医学工程, 2017, 25(2): 1-3. [60] Pedanekar T, Kedare R, Sengupta A. Monitoring tumor progression by mapping skin microcirculation with laser Doppler flowmetry[J]. Lasers Med Sci, 2019, 34(1): 61-77. [61] Rohleder NH, Flensberg S, Bauer F, et al. Can tissue spectrophotometry and laser Doppler flowmetry help to identify patients at risk for wound healing disorders after neck dissection?[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(3): 302-311. [62] 王卓群, 刘文科, 尹良军. 皮肤微循环监测技术的研究进展[J]. 世界最新医学信息文摘, 2019, 19(98): 87-89,92. [63] 于小晰, 刘暴. 下肢组织灌注评估及动脉自旋标记技术的应用进展[J]. 中国微创外科杂志, 2021, 21(8): 721-725. [64] 刘亮, 李小鹰, 赵秀梅, 等. 激光多普勒血流图像仪检测老年下肢动脉硬化闭塞症的临床疗效[J]. 中华老年心脑血管病杂志, 2003, 5(6): 368-370. [65] Smirni S, Macdonald MP, Robertson CP, et al. Application of cmOCT and continuous wavelet transform analysis to the assessment of skin microcirculation dynamics[J]. J Biomed Opt, 2018, 23(7): 1-13. [66] Roustit M, Cracowski JL. Non‐invasive assessment of skin microvascular function in humans: An Insight Into Methods[J]. Microcirculation. 2012, 19(1):47-64. [67] 陈程. 激光散斑对比成像系统(LSCI)在瘢痕疙瘩诊疗体系中的应用[D]. 北京协和医学院, 2018. [68] Heeman W, Steenbergen W, Van Dam GM, et al. Clinical applications of laser speckle contrast imaging: a review[J]. J Biomed Opt, 2019, 24(8): 080901. [69] Omarjee L, Larralde A, Jaquinandi V, et al. Performance of noninvasive laser Doppler flowmetry and laser speckle contrast imaging methods in diagnosis of Buerger disease[J]. Medicine, 2018, 97(43): e12979. [70] Katsui S, Inoue Y, Igari K, et al. Novel assessment tool based on laser speckle contrast imaging to diagnose severe ischemia in the lower limb for patients with peripheral arterial disease[J]. Lasers Surg Med, 2017, 49(7): 645-651. [71] Mennes OA, Van Netten JJ, Van Baal JG, et al. Assessment of microcirculation in the diabetic foot with laser speckle contrast imaging[J]. Physiol Meas, 2019, 40(6): 065002. [72] 王淼, 洪嘉驰, 周非凡, 等. 激光散斑成像技术在脑科学研究中的应用[J]. 生物化学与生物物理进展, 2021, 48(8): 922-937. [73] Potapova E, Seryogina E, Dremin V, et al. Laser speckle contrast imaging of blood microcirculation in pancreatic tissues during laparoscopic interventions[J]. Quantum Electronics, 2020, 50: 33-40. [74] Xu X, Wang W, Wang Z, et al. DW14006 as a direct AMPKα activator ameliorates diabetic peripheral neuropathy in mice[J]. Diabetes, 2020, 69(9): 1974-1988. [75] Schaper NC, Andros G, Apelqvist J, et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the international working group on the diabetic foot[J]. Diabetes Metab Res Rev, 2012, 28 (Suppl 1): 218-224. [76] Abou-Zamzam Jr AM, Gomez NR, Molkara A, et al. A prospective analysis of critical limb ischemia: factors leading to major primary amputation versus revascularization[J]. Ann Vasc Surg, 2007, 21(4): 458-463. [77] Mahé G, Catillon F, Tollenaere Q, et al. Discordance of peripheral artery disease diagnosis using exercise transcutaneous oxygen pressure measurement and post-exercise ankle-brachial index[J]. Sci Rep, 2020, 10(1): 7419. [78] Mittleider D. Noninvasive arterial testing: what and when to use[J]. Semin Intervent Radiol, 2018, 35(5): 384-392. [79] Mccann TE, Scoutt LM, Gunabushanam G. A practical approach to interpreting lower extremity noninvasive physiologic studies[J]. Radiol Clin North Am, 2014, 52(6): 1343-1357. [80] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II)[J]. Eur J Vasc Endovasc Surg, 2007, 45(1): S5-S67. [81] Lewis JE, Owens DR. The pulse volume recorder as a measure of peripheral vascular status in people with diabetes mellitus[J]. Diabetes Technol Ther, 2010, 12(1): 75-80. [82] 王莉. 趾臂指数在早期糖尿病下肢血管病变中的诊断价值及下肢血管病变危险因素的研究[D].张家口:河北北方学院, 2014. [83] Casey SL, Lanting SM, Chuter VH. The ankle brachial index in people with and without diabetes: intra-tester reliability[J]. J Foot Ankle Res, 2020, 13(1): 21. [84] 唐明华. 踝臂、趾臂指数与脉搏波速度在2型糖尿病下肢动脉病变患者诊断中的价值[D].大连:大连医科大学, 2018. [85] Herraiz-Adillo Á, Cavero-Redondo I, Álvarez-Bueno C, et al. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis[J]. Atherosclerosis, 2020, 31581-92. [86] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4-67. [87] Jeevanantham V, Chehab B, Austria E, et al. Comparison of accuracy of two different methods to determine ankle-brachial index to predict peripheral arterial disease severity confirmed by angiography[J]. Am J Cardiol, 2014, 114(7): 1105-1110. [88] 刘松涛, 苏海, 李萍. 四肢血压测量诊断外周动脉疾病的价值[J]. 中华高血压杂志, 2019, 27(2): 184-187. [89] Trevethan R. Subjecting the ankle-brachial index to timely scrutiny: is it time to say goodbye to the ABI?[J]. Scand J Clin Lab Invest, 2018, 78(1-2): 94-101. [90] Barshes NR, Flores E, Belkin M, et al. The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers[J]. J Vasc Surg, 2016, 64(6): 1682-1690.e3. [91] Xu D, Li J, Zou L, et al. Sensitivity and specificity of the ankle--brachial index to diagnose peripheral artery disease: a structured review[J]. Vasc Med, 2010, 15(5): 361-369. [92] 吴娟丽, 郑亮, 郭琪, 等. 踝臂指数对糖尿病合并外周动脉疾病诊断价值的meta分析[J]. 同济大学学报(医学版), 2014, 35(2): 116-122. [93] Guirguis-Blake JM, Evans CV, Redmond N, et al. Screening for peripheral artery disease using the ankle-brachial index: updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2018, 320(2): 184-196. [94] Curry SJ, Krist AH, Owens DK, et al. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US preventive services task force recommendation statement[J]. JAMA, 2018, 320(2): 177-183. [95] Yang SL, Zhu LY, Han R, et al. Pathophysiology of peripheral arterial disease in diabetes mellitus[J]. J Diabetes, 2017, 9(2): 133-140. [96] Kim HL, Kim SH. Pulse wave velocity in atherosclerosis[J]. Front Cardiovasc Med, 2019, 6:41. [97] Wakasugi S, Mita T, Katakami N, et al. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2021, 20(1): 15. [98] Milan A, Zocaro G, Leone D, et al. Current assessment of pulse wave velocity: comprehensive review of validation studies[J]. J Hypertens, 2019, 37(8): 1547-1557. [99] Kim JM, Kim SS, Kim IJ, et al. Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the rebound study[J]. Cardiovasc Diabetol, 2020, 19(1): 143. [100] Sugawara J, Tanaka H. Brachial-ankle pulse wave velocity: myths, misconceptions, and realities[J]. Pulse, 2015, 3(2): 106-113. [101] Isabella T, Mark B, Bart S, et al. Effect of heart rate on arterial stiffness as assessed by pulse wave velocity[J]. Current Hypertension Rev, 2018, 14(2): 107-122. [102] Varaki ES, Gargiulo G, Penkala S, et al. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods[J]. BioMed Eng OnLine, 2018, 17(1):61. [103] Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications[J]. Eur Heart J, 2006, 27(21): 2588-2605. [104] 何伟红, 方挺松, 柯祺, 等. MSCTA诊断糖尿病足溃疡下肢动脉疾病的临床应用价值[J]. 实用放射学杂志, 2017, 33(7): 1077-1079,1087. [105] 戴正行, 居敏昊, 王婷. MSCTA不同图像后处理技术诊断常见下肢动脉病变的准确性观察[J]. 中国CT和MRI杂志, 2017,15(8):149-152. [106] Mohammedi K, Woodward M, Marre M, et al. Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2017, 16(1): 95. [107] Mohammedi K, Woodward M, Hirakawa Y, et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes[J]. Diabetes Care, 2016, 39(10): 1796-1803. [108] Beckman JA, Duncan MS, Damrauer SM, et al. Microvascular disease, peripheral artery disease, and amputation[J]. Circulation, 2019, 140(6): 449-458. [109] Behroozian A, Beckman JA. Microvascular disease increases amputation in patients with peripheral artery disease[J]. Arterioscler Thromb Vasc Biol, 2020, 40(3): 534-540. [110] 陆冰, 胡秋菊, 刘晔, 等. 糖尿病合并肌痛一例报道[J]. 中国糖尿病杂志, 2018, 26(7): 605-607. [111] Lu X, Sun J, Bai JJ, et al. Investigation and analysis of lower extremity arterial disease in hospitalized elderly type 2 diabetic patients[J]. Int J Nurs Sci, 2018, 5(1): 45-49. [112] 田丽, 叶春芳, 刘志伟, 等. 2型糖尿病周围神经病变与双下肢血管病变关系的分析[J]. 西北药学杂志, 2015, 30(1): 76-78. [113] Guang-ran YA, Hong-bing L, Shen-Yuan YU. Sensory nerve function in diabetic patients and its relationship with lower extremity arterial disease[J]. Chinese J Diabetes, 2004, 12(1): 399-401. [114] Gotschy A, Bauer WR, Winter P, et al. Local versus global aortic pulse wave velocity in early atherosclerosis: an animal study in apoe-/--mice using ultrahigh field MRI[J]. PLoS ONE, 2017, 12(2): e0171603.
